Top compounds associated with response to LEMD2


Feature Type Standardized
Nominal ANOVA
mRNA KHS101 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA PD173074 GDSC1000 pan-cancer AAC -0.042 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA etoposide GDSC1000 pan-cancer AAC 0.041 0.2
mRNA Docetaxel gCSI pan-cancer AAC -0.067 0.2
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.043 0.2
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.043 0.2
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.039 0.2
Download CSV